Department of Urology, Yeungnam University College of Medicine, Daegu, Korea
Copyright © 2023 Yeungnam University College of Medicine, Yeungnam University Institute of Medical Science
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Variable | Data |
---|---|
No. of patients | 107 |
Age (yr) | 66.50±6.29 |
Prostate volume (mL) | 30.26±12.52 |
Preoperative PSA (ng/mL) | 17.46±27.42 |
Duration of catheterization (day) | 8.16±3.11 |
Pathologic state | |
≤T2 | 57 (53.3) |
≥T3 | 50 (46.7) |
NVB sparing | |
Unilateral | 24 (22.4) |
Bilateral | 83 (77.6) |
Bladder neck preservation | 67 (62.6) |
Recovery of incontinence (mo) | |
1 | 47 (43.9) |
3 | 71 (66.4) |
6 | 94 (87.9) |
12 | 104 (97.2) |
Regain of continence (day) | 79.88±86.21 |
Factor | 1 Mo |
3 Mo |
6 Mo |
12 Mo |
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Incontinence (n=60) | Continence (n=47) | p-value | Incontinence (n=36) | Continence (n=71) | p-value | Incontinence (n=13) | Continence (n=94) | p-value | Incontinence (n=3) | Continence (n=104) | p-value | |
Age (yr) | 66.23±6.17 | 66.83±6.48 | 0.629 | 65.92±6.14 | 66.79±6.38 | 0.500 | 67.54±5.82 | 66.35±6.36 | 0.526 | 63.33±6.65 | 66.59±6.28 | 0.379 |
Prostate volume (mL) | 32.45±14.56 | 27.46±8.64 | 0.04 | 29.92±12.35 | 30.43±12.68 | 0.843 | 29.57±12.04 | 30.35±12.64 | 0.834 | 42.09±16.89 | 29.91±12.31 | 0.097 |
Preoperative PSA (ng/mL) | 16.05±24.06 | 19.26±31.37 | 0.551 | 20.27±29.64 | 16.04±26.32 | 0.454 | 15.15±16.53 | 17.78±28.65 | 0.748 | 6.05±3.01 | 17.79±27.74 | 0.467 |
Pathologic stage (n) | 0.115 | 0.942 | 0.524 | 0.100 | ||||||||
T2 | 36 | 21 | 19 | 38 | 8 | 49 | 3 | 54 | ||||
T3 | 24 | 26 | 17 | 33 | 5 | 45 | 0 | 50 | ||||
NVB sparing (n) | 0.800 | 0.345 | 0.139 | 0.345 | ||||||||
Unilateral | 14 | 10 | 10 | 14 | 5 | 19 | 0 | 24 | ||||
Bilateral | 46 | 37 | 26 | 57 | 8 | 75 | 3 | 80 | ||||
Bladder neck preservation | 29 | 38 | 0.001 | 19 | 48 | 0.134 | 5 | 62 | 0.055 | 1 | 66 | 0.288 |
Postoperative cystography parameter | ||||||||||||
BNAP ratio | 0.267±0.059 | 0.188±0.022 | <0.001 | 0.299±0.047 | 0.198±0.031 | <0.001 | 0.335±0.032 | 0.217±0.048 | <0.001 | 0.336±0.055 | 0.229±0.058 | 0.002 |
Vesicourethral angle | 98.51±12.14 | 116.29±5.41 | <0.001 | 94.84±11.26 | 112.15±9.85 | <0.001 | 90.13±9.97 | 108.56±11.96 | <0.001 | 82.60±189.01 | 107.01±12.46 | 0.001 |
BNPS ratio | 0.509±0.163 | 0.410±0.155 | 0.002 | 0.526±0.165 | 0.434±0.160 | 0.007 | 0.574±0.186 | 0.450±0.159 | 0.011 | 0.585±0.235 | 0.462±0.164 | 0.210 |
Factor | Postoperative 1 mo (47/107) |
Postoperative 3 mo (71/107) |
Postoperative 6 mo (94/107) |
|||
---|---|---|---|---|---|---|
OR (95% CI) | p-value | OR (95% CI) | p-value | OR (95% CI) | p-value | |
Age (yr) | 0.943 (0.838–1.062) | 0.336 | 1.039 (0.888–1.217) | 0.631 | 0.919 (0.718–1.175) | 0.501 |
Prostate volume (mL) | 1.092 (1.020–1.170) | 0.012 | 1.030 (0.950–1.118) | 0.471 | 1.024 (0.920–1.141) | 0.661 |
Preoperative PSA (ng/mL) | 0.997 (0.968–1.027) | 0.851 | 1.036 (1.000–1.074) | 0.051 | 1.029 (0.943–1.123) | 0.524 |
Pathologic stage | 1.248 (0.192–8.096) | 0.817 | 0.142 (0.013–1.499) | 0.105 | 8.945 (0.115–98.425) | 0.524 |
NVB sparing | 1.684 (0.188–15.065) | 0.641 | 0.044 (0.002–1.223) | 0.066 | 3.177 (0.222–45.477) | 0.139 |
No bladder neck preservation | 0.279 (0.057–1.367) | 0.115 | 4.290 (0.369–49.912) | 0.245 | 0.147 (0.014–1.516) | 0.107 |
BNAP ratio | 3.795 (2.829–5.089) | 0.006 | 3.867 (2.181–5.384) | <0.001 | 3.648 (2.694–5.041) | 0.002 |
Vesicourethral angle | 0.800 (0.701–0.913) | 0.001 | 0.885 (0.806–0.971) | 0.010 | 0.866 (0.765–0.980) | 0.023 |
BNPS ratio | 0.098 (0.000–34.073) | 0.436 | 0.013 (0.000–9.100) | 0.193 | 7.155 (0.024–21.325) | 0.295 |
Factor | HR (95% CI) | p-value |
---|---|---|
Age (yr) | 1.029 (0.995–1.063) | 0.092 |
Prostate volume (mL) | 0.993 (0.976–1.010) | 0.412 |
Preoperative PSA (ng/mL) | 1.001 (0.993–1.009) | 0.880 |
Pathologic stage (T3) | 0.786 (0.501–1.232) | 0.293 |
Bilateral NVB sparing | 1.061 (0.527–2.138) | 0.868 |
No bladder neck preservation | 0.608 (0.393–0.938) | 0.025 |
BNAP ratio | 0.416 (0.146–0.987) | <0.001 |
Vesicourethral angle | 1.056 (1.032–1.080) | <0.001 |
BNPS ratio | 0.924 (0.208–4.109) | 0.917 |
Parameter | Sensitivity | Specificity | Youden’s index | Optimal cut-off | AUC | 95% CI | p-value |
---|---|---|---|---|---|---|---|
BNPS ratio | 0.350 | 0.957 | 0.307 | 0.584 | 0.650 | 0.546–0.754 | 0.008 |
Vesicourethral angle | 0.915 | 0.817 | 0.732 | 108.5 | 0.918 | 0.866–0.970 | <0.001 |
BNAP ratio | 0.800 | 0.979 | 0.779 | 0.224 | 0.898 | 0.835–0.961 | <0.001 |
Values are presented as number only, mean±standard deviation, or number (%). PSA, prostate-specific antigen; NVB, neurovascular bundle.
Values are presented as mean±standard deviation or number. PPI, post-prostatectomy incontinence; PSA, prostate-specific antigen; NVB, neurovascular bundle; BNAP, bladder neck anteroposterior length; BNPS, bladder neck to pubic symphysis.
PPI, post-prostatectomy incontinence; OR, odds ratio; CI, confidence interval; PSA, prostate-specific antigen; NVB, neurovascular bundle; BNAP, bladder neck anteroposterior; BNPS, bladder neck to pubic symphysis.
PPI, post-prostatectomy incontinence; HR, hazard ratio; CI, confidence interval; PSA, prostate-specific antigen; NVB, neurovascular bundle; BNAP, bladder neck anteroposterior; BNPS, bladder neck to pubic symphysis.
ROC, receiver operating characteristic; AUC, area under the curve; CI, confidence interval; BNPS, bladder neck to pubic symphysis; BNAP, bladder neck anteroposterior.